Workflow
Weighted Average Cost of Capital (WACC)
icon
Search documents
Comparative Analysis of ROIC and WACC Across Chinese Tech Companies
Financial Modeling Prep· 2025-12-16 17:00
Core Viewpoint - Tuniu Corporation is facing challenges in capital management, as indicated by its negative Return on Invested Capital (ROIC) compared to its Weighted Average Cost of Capital (WACC), which raises concerns for investors [2][6]. Financial Performance - Tuniu's ROIC is -0.184%, while its WACC is 9.98%, resulting in a ROIC to WACC ratio of -0.018, indicating inefficiency in capital management [2][6]. - Cheetah Mobile Inc. has a ROIC of -12.23% and a WACC of 3.58%, leading to a more significant ROIC to WACC ratio of -3.41, highlighting greater inefficiency than Tuniu [3][6]. - Leju Holdings Limited presents a severe case with a ROIC of -540.32% and a WACC of 366.63%, resulting in a ROIC to WACC ratio of -1.47, making it less attractive to investors [4][6]. - Xunlei Limited has the highest ROIC to WACC ratio among peers at -0.23, despite a negative ROIC of -1.12% and WACC of 4.74%, suggesting relatively better capital management efficiency [5][6].
Marchex's Capital Utilization Challenges Compared to Peers
Financial Modeling Prep· 2025-12-14 17:00
Marchex, Inc. (NASDAQ:MCHX) has a negative ROIC to WACC ratio of -1.28, indicating poor capital efficiency.QuinStreet, Inc. (QNST) and Liquidity Services, Inc. (LQDT) show more favorable financial positions with positive ROIC to WACC ratios, suggesting better capital utilization.Maiden Holdings, Ltd. (MHLD) also struggles with capital efficiency, having an even less favorable ROIC to WACC ratio than Marchex.Marchex, Inc. (NASDAQ:MCHX) is a company that specializes in call analytics and call tracking solutio ...
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Financial Analysis
Financial Modeling Prep· 2025-12-14 17:00
Core Insights - Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases, currently not generating significant revenue [1] - The company operates in a sector characterized by a focus on research and development rather than immediate profitability [5] Financial Metrics - Soleno's Return on Invested Capital (ROIC) is -15.74%, with a Weighted Average Cost of Capital (WACC) of 4.67%, resulting in a ROIC to WACC ratio of -3.37, indicating it is not generating returns that exceed its cost of capital [2] - In comparison, Akari Therapeutics has a ROIC of -64.44% and a WACC of 3.75%, leading to a ROIC to WACC ratio of -17.18, while Leap Therapeutics shows a ROIC of -37.62% and a WACC of 4.69, with a ratio of -8.02 [3] - Tenax Therapeutics has the highest ROIC to WACC ratio among peers at -4.39, despite a ROIC of -48.59% and a WACC of 11.07, suggesting it is relatively closer to covering its cost of capital [4] Industry Overview - All companies in the peer group, including Soleno Therapeutics, are experiencing negative ROIC, which is typical for clinical-stage biopharmaceutical companies in the investment phase [5]
Financial Challenges Faced by Forian Inc. and Its Peers in the Healthcare Sector
Financial Modeling Prep· 2025-12-14 02:00
Core Insights - Forian Inc. is facing significant financial challenges with a negative Return on Invested Capital (ROIC) of -13.42% and a ROIC to Weighted Average Cost of Capital (WACC) ratio of -1.52, indicating it is not generating returns above its cost of capital [1][6] Company Performance - Forian Inc. has a ROIC of -13.42% and a WACC of 8.81% [1] - The ROIC to WACC ratio for Forian is -1.52, showing underperformance in generating returns [1][6] Peer Comparison - Ikena Oncology, Inc. has a ROIC of -36.02% and a WACC of 6.18%, resulting in a ROIC to WACC ratio of -5.83 [2] - Finch Therapeutics Group, Inc. reports a ROIC of -38.62% against a WACC of 6.18%, leading to a ratio of -6.25 [2] - NeuroPace, Inc. has a ROIC of -20.32% and a WACC of 12.43%, resulting in a ROIC to WACC ratio of -1.63, indicating it is relatively closer to breaking even [3] - Eledon Pharmaceuticals, Inc. has a ROIC of -75.00% and a WACC of 7.50%, leading to a ROIC to WACC ratio of -10.00 [4] - Werewolf Therapeutics, Inc. reports a ROIC of -87.96% against a WACC of 9.55%, resulting in a ratio of -9.21 [4] Industry Overview - The industry is facing widespread challenges, with all mentioned companies struggling to generate returns that exceed their cost of capital [5][6] - NeuroPace, Inc. shows the most potential for improvement among its peers, with the least negative ROIC to WACC ratio of -1.63 [5][6]
International Seaways, Inc. (NYSE:INSW) Performance in the Shipping Industry
Financial Modeling Prep· 2025-12-13 02:00
Core Insights - International Seaways, Inc. (NYSE: INSW) is a key player in the shipping industry, focusing on the transportation of crude oil and petroleum products with a diverse fleet of vessels [1] Financial Performance - INSW's Return on Invested Capital (ROIC) is 8.85%, while its Weighted Average Cost of Capital (WACC) is 5.19%, resulting in a ROIC to WACC ratio of 1.70, indicating efficient capital utilization [2] - Scorpio Tankers Inc. has a ROIC of 8.01% and a WACC of 6.39%, leading to a ROIC to WACC ratio of 1.25, which is lower than INSW's, suggesting less efficiency in generating returns [3] - Euronav N.V. has a high ROIC of 18.03% against a WACC of 6.98%, resulting in a ROIC to WACC ratio of 2.58, indicating superior capital utilization compared to INSW [3] - Teekay Tankers Ltd. shows a ROIC of 12.88% and a WACC of 4.89%, achieving the highest ROIC to WACC ratio of 2.63 among peers, outperforming INSW in capital efficiency [4]
Accelerant Holdings (NASDAQ:ARX) Financial Analysis and Peer Comparison
Financial Modeling Prep· 2025-12-12 17:00
Core Insights - Accelerant Holdings operates in the financial sector, focusing on insurance and reinsurance solutions, aiming to provide innovative risk management services [1] - The company has a Return on Invested Capital (ROIC) of 0.85%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 5.05%, indicating inefficient capital utilization [2][6] - CompX International Inc. demonstrates strong capital efficiency with a ROIC of 12.03% and a WACC of 8.74%, suggesting potential for growth [3][6] - CIMG Inc. shows the most concerning figures with a ROIC of -78.08% and a WACC of 6.34%, indicating significant inefficiencies in capital utilization [5][6] Comparison with Peers - SuperX AI Technology Limited has a negative ROIC of -14.33% against a WACC of 4.66%, indicating poor capital utilization [3] - Albany International Corp. has a negative ROIC of -2.66% with a WACC of 8.80%, resulting in a ROIC to WACC ratio of -0.30 [4] - Mistras Group, Inc. has a ROIC of 5.99% and a WACC of 7.82%, indicating moderate capital efficiency [4] - Overall, while CompX International Inc. shows strong capital efficiency, Accelerant Holdings and several peers face challenges in generating returns above their cost of capital [5]
Nu Holdings Ltd. (NYSE:NU) Financial Analysis
Financial Modeling Prep· 2025-12-12 02:00
Core Insights - Nu Holdings Ltd. is a leading digital banking platform in Latin America, offering services such as credit cards, personal loans, and savings accounts, and is recognized for its innovative use of technology in banking [1] - The competitive landscape includes other fintech companies like StoneCo Ltd. and SoFi Technologies, which present varying levels of financial performance [1] Financial Performance - Nu Holdings has a Return on Invested Capital (ROIC) of 14.58%, exceeding its Weighted Average Cost of Capital (WACC) of 11.56%, indicating positive returns for investors [2][6] - The ROIC to WACC ratio for Nu Holdings is 1.26, demonstrating efficient capital utilization [2] - StoneCo Ltd. shows a significantly higher ROIC of 38.53% against a WACC of 10.70%, resulting in a ROIC to WACC ratio of 3.60, indicating superior capital management [3][6] - In contrast, SoFi Technologies has a ROIC of 5.19% with a WACC of 14.72%, leading to a ROIC to WACC ratio of 0.35, suggesting challenges in generating adequate returns [4][6] - Toast, Inc. has a ROIC of 11.43% and a WACC of 12.88%, resulting in a ROIC to WACC ratio of 0.89, indicating it is close to breaking even but still not generating returns above its cost of capital [5][6] - Overall, the analysis highlights varying efficiencies in capital utilization among digital banking platforms, with StoneCo leading the sector [5][6]
Vivid Seats Inc. (NASDAQ:SEAT) Financial Performance and Capital Utilization Challenges
Financial Modeling Prep· 2025-12-11 17:00
Core Insights - Vivid Seats Inc. operates as an online ticket marketplace but faces significant financial challenges, particularly in capital utilization efficiency [1][6] Financial Performance - Vivid Seats has a Return on Invested Capital (ROIC) of -61.41%, which is substantially lower than its Weighted Average Cost of Capital (WACC) of 5.00%, indicating inefficiencies in capital utilization [2][6] - In contrast, Sovos Brands, Inc. has a positive ROIC of 5.54% and a WACC of 5.21%, suggesting effective capital utilization and value creation for shareholders [3][6] - Bowlero Corp. and CareMax, Inc. also show negative ROICs of -114.39% and -117.47%, respectively, highlighting similar inefficiencies in capital utilization despite differing business models [4][6] - Stagwell Inc. presents a mixed financial picture with a positive ROIC of 3.11% but a WACC of 4.23%, indicating that while returns are generated, they are insufficient to cover the cost of capital [5][6]
Motorsport Games Inc. (NASDAQ:MSGM) Financial Performance Analysis
Financial Modeling Prep· 2025-12-11 17:00
Core Insights - Motorsport Games Inc. specializes in developing and publishing racing video games, catering to motorsport enthusiasts in a competitive industry [1] - The company has a favorable Return on Invested Capital (ROIC) of 17.83% compared to its Weighted Average Cost of Capital (WACC) of 13.59), resulting in a positive ROIC to WACC ratio of 1.31, indicating efficient capital utilization [2][6] Comparison with Peers - Genius Group Limited has a negative ROIC of -24.56% and a WACC of 22.71%, leading to a negative ROIC to WACC ratio of -1.08, suggesting insufficient returns to cover its cost of capital [3] - Versus Systems Inc. shows a significantly negative ROIC of -60.78% against a WACC of 13.17%, resulting in a ROIC to WACC ratio of -4.61, highlighting severe inefficiencies in capital utilization [4] - Cosmos Health Inc. and Magic Empire Global Limited also exhibit negative ROIC to WACC ratios of -2.49 and -0.48, respectively, indicating struggles in generating adequate returns compared to Motorsport Games Inc. [5][6]
FinWise Bancorp's Competitive Edge in Banking Sector
Financial Modeling Prep· 2025-12-10 02:00
Core Insights - FinWise Bancorp demonstrates a strong Return on Invested Capital (ROIC) of 30.90% and a Weighted Average Cost of Capital (WACC) of 12.15%, resulting in a ROIC to WACC ratio of 2.54, indicating superior efficiency in capital utilization [2][5] - In comparison, peers such as Third Coast Bancshares and Southern States Bancshares exhibit significantly lower ROIC to WACC ratios of 0.33 and 0.53 respectively, suggesting less efficiency in generating returns relative to their cost of capital [3][5] - USCB Financial Holdings shows a ROIC to WACC ratio of 0.62, indicating potential for growth but still trailing behind FinWise's performance [4] - Five Star Bancorp and Primis Financial Corp. have even lower ratios of 0.09 and 0.08 respectively, highlighting their challenges in achieving returns above their cost of capital [4][5]